Related Experiment Video

Updated: May 14, 2026

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Plasma copeptin concentration and outcome after pediatric traumatic brain injury

Chao Lin1, Ning Wang, Zhi-Peng Shen

  • 1Department of Neurosurgery, The Children's Hospital, Zhejiang University, School of Medicine, Hangzhou 310003, China.

Peptides
|February 14, 2013
PubMed

Insights

Elevated plasma copeptin levels in children with traumatic brain injury (TBI) predict poor outcomes. This biomarker shows potential for predicting mortality and unfavorable outcomes following TBI.

Area of Science:

  • Biomarkers in pediatric critical care
  • Neurology and neurosurgery
  • Clinical diagnostics

Background:

  • Higher plasma copeptin levels are linked to adverse outcomes in critical illness.
  • Traumatic brain injury (TBI) in children can lead to severe consequences.

Purpose of the Study:

  • To measure plasma copeptin concentrations in children with acute severe TBI.
  • To analyze the correlation between copeptin levels and disease outcomes at 6 months post-injury.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure plasma copeptin.
  • Plasma copeptin levels were compared between 126 children with TBI and 126 healthy children.
  • Statistical analysis included odds ratios, confidence intervals, and area under the curve (AUC) for predictive value.

Main Results:

  • Children with TBI had significantly higher plasma copeptin levels than healthy children (46.2±20.8 pmol/L vs. 9.6±3.0 pmol/L, P<0.001).
  • Plasma copeptin was an independent predictor of 6-month mortality (OR 1.261) and unfavorable outcome (OR 1.313).
  • Copeptin improved the predictive accuracy for unfavorable outcomes when combined with the Glasgow Coma Scale (GCS) score.

Conclusions:

  • Plasma copeptin is a novel and valuable biomarker for predicting 6-month clinical outcomes in pediatric TBI.
  • Copeptin levels offer significant predictive value for mortality and functional recovery in children with TBI.
  • Further research can explore the clinical utility of copeptin in TBI management.

More Related Videos

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery04:01

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery

Published on: August 9, 2024

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

Related Concept Videos

Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...